FDA approves Roche drug for rare type of blood cancer

(Reuters) – Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer.


Source: Reuters Health News